CCL21

CCL21
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesCCL21, 6Ckine, CKb9, ECL, SCYA21, SLC, TCA4, C-C motif chemokine ligand 21
External IDsOMIM: 602737 MGI: 1349183 HomoloGene: 2247 GeneCards: CCL21
Gene location (Human)
Chr.Chromosome 9 (human)[1]
Band9p13.3Start34,709,005 bp[1]
End34,710,124 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

6366

18829

Ensembl

ENSG00000137077

ENSMUSG00000094686

UniProt

O00585

P84444

RefSeq (mRNA)

NM_002989

NM_011124

RefSeq (protein)

NP_002980

NP_035254

Location (UCSC)Chr 9: 34.71 – 34.71 MbChr 4: 42.77 – 42.77 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Chemokine (C-C motif) ligand 21 (CCL21) is a small cytokine belonging to the CC chemokine family. This chemokine is also known as 6Ckine (because it has six conserved cysteine residues instead of the four cysteines typical to chemokines), exodus-2, and secondary lymphoid-tissue chemokine (SLC).[5][6][7] The gene for CCL21 is located on human chromosome 9. CCL21 elicits its effects by binding to a cell surface chemokine receptor known as CCR7.[8]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000137077 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000094686 - Ensembl, May 2017
  3. "Human PubMed Reference:".
  4. "Mouse PubMed Reference:".
  5. Hedrick JA, Zlotnik A (1997). "Identification and characterization of a novel beta chemokine containing six conserved cysteines". J. Immunol. 159 (4): 1589–93. PMID 9257816.
  6. Hromas R, Kim CH, Klemsz M, Krathwohl M, Fife K, Cooper S, Schnizlein-Bick C, Broxmeyer HE (1997). "Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension". J. Immunol. 159 (6): 2554–8. PMID 9300671.
  7. Nagira M, Imai T, Hieshima K, Kusuda J, Ridanpää M, Takagi S, Nishimura M, Kakizaki M, Nomiyama H, Yoshie O (1997). "Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13". J. Biol. Chem. 272 (31): 19518–24. doi:10.1074/jbc.272.31.19518. PMID 9235955.
  8. Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O (1998). "Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7". J. Biol. Chem. 273 (12): 7118–22. doi:10.1074/jbc.273.12.7118. PMID 9507024.

Further reading

  • Nagira M, Imai T, Hieshima K, et al. (1997). "Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13". J. Biol. Chem. 272 (31): 19518–24. doi:10.1074/jbc.272.31.19518. PMID 9235955.
  • Hedrick JA, Zlotnik A (1997). "Identification and characterization of a novel beta chemokine containing six conserved cysteines". J. Immunol. 159 (4): 1589–93. PMID 9257816.
  • Hromas R, Kim CH, Klemsz M, et al. (1997). "Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension". J. Immunol. 159 (6): 2554–8. PMID 9300671.
  • Gunn MD, Tangemann K, Tam C, et al. (1998). "A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes". Proc. Natl. Acad. Sci. U.S.A. 95 (1): 258–63. doi:10.1073/pnas.95.1.258. PMC 18193. PMID 9419363.
  • Yoshida R, Nagira M, Kitaura M, et al. (1998). "Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7". J. Biol. Chem. 273 (12): 7118–22. doi:10.1074/jbc.273.12.7118. PMID 9507024.
  • Campbell JJ, Bowman EP, Murphy K, et al. (1998). "6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7". J. Cell Biol. 141 (4): 1053–9. doi:10.1083/jcb.141.4.1053. PMC 2132769. PMID 9585422.
  • Jenh CH, Cox MA, Kaminski H, et al. (1999). "Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors". J. Immunol. 162 (7): 3765–9. PMID 10201891.
  • Gosling J, Dairaghi DJ, Wang Y, et al. (2000). "Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK". J. Immunol. 164 (6): 2851–6. doi:10.4049/jimmunol.164.6.2851. PMID 10706668.
  • Annunziato F, Romagnani P, Cosmi L, et al. (2000). "Macrophage-derived chemokine and EBI1-ligand chemokine attract human thymocytes in different stage of development and are produced by distinct subsets of medullary epithelial cells: possible implications for negative selection". J. Immunol. 165 (1): 238–46. doi:10.4049/jimmunol.165.1.238. PMID 10861057.
  • Hirose J, Kawashima H, Yoshie O, et al. (2001). "Versican interacts with chemokines and modulates cellular responses". J. Biol. Chem. 276 (7): 5228–34. doi:10.1074/jbc.M007542200. PMID 11083865.
  • Till KJ, Lin K, Zuzel M, Cawley JC (2002). "The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes". Blood. 99 (8): 2977–84. doi:10.1182/blood.V99.8.2977. PMID 11929789.
  • Grant AJ, Goddard S, Ahmed-Choudhury J, et al. (2002). "Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease". Am. J. Pathol. 160 (4): 1445–55. doi:10.1016/S0002-9440(10)62570-9. PMC 1867219. PMID 11943728.
  • Banas B, Wörnle M, Berger T, et al. (2002). "Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis". J. Immunol. 168 (9): 4301–7. doi:10.4049/jimmunol.168.9.4301. PMID 11970971.
  • Christopherson KW, Hood AF, Travers JB, et al. (2003). "Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases". Blood. 101 (3): 801–6. doi:10.1182/blood-2002-05-1586. PMID 12393410.
  • Stein JV, Soriano SF, M'rini C, et al. (2003). "CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway". Blood. 101 (1): 38–44. doi:10.1182/blood-2002-03-0841. PMID 12393730.
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
  • Wolf M, Clark-Lewis I, Buri C, et al. (2003). "Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer". Am. J. Pathol. 162 (4): 1183–90. doi:10.1016/S0002-9440(10)63914-4. PMC 1851240. PMID 12651610.
  • Weninger W, Carlsen HS, Goodarzi M, et al. (2003). "Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis". J. Immunol. 170 (9): 4638–48. doi:10.4049/jimmunol.170.9.4638. PMID 12707342.
  • Nagakubo D, Murai T, Tanaka T, et al. (2003). "A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines". J. Immunol. 171 (2): 553–61. doi:10.4049/jimmunol.171.2.553. PMID 12847218.
  • Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.